Login to Your Account



Deals And M&A NEWS

DUBLIN – Domain Therapeutics SA could receive up to €240 million in an up-front payment, potential milestones and eventual sales royalties from a licensing deal with Merck KgaA on its preclinical program of adenosine receptor modulators.

HONG KONG – Small South Korean biopharma firm Legochem Biosciences Inc. is looking to turbo-charge its operations by partnering with Takeda Pharmaceuticals Co. Ltd., one of just two companies that has successfully commercialized an antibody-drug conjugate (ADC) drug.

The acquisition of two partner-ready nanoparticle cancer candidates developed by Azaya Therapeutics Inc. and an associated nanotech platform could yield potential near-term revenue for Cytori Therapeutics Inc.

More Deals And M&A Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: